Amneal Pharmaceuticals Inc (FRA:2DT)
€ 7.25 -0.05 (-0.68%) Market Cap: 2.31 Bil Enterprise Value: 4.84 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 66/100

Q2 2021 Amneal Pharmaceuticals Inc Earnings Call Transcript

Aug 09, 2021 / 12:00PM GMT
Release Date Price: €4.06 (-2.87%)
Operator

Good morning, and welcome to Amneal's Second Quarter 2021 Earnings Call. (Operator Instructions) Please note, this event is being recorded.

I would now like to turn the conference over to Amneal's Head of Investor Relations, Tony DiMeo. Please go ahead.

Anthony DiMeo
Amneal Pharmaceuticals, Inc. - Senior Director of IR

Good morning, and thank you for joining Amneal's Second Quarter 2021 Earnings Call. Today, we issued a press release reporting our financial results. The press release and presentation are available on our website at amneal.com. We are conducting a live webcast of this call, a replay of which will also be available on our website after its conclusion.

Please note that certain statements made during this call regarding matters that are not historical facts, including, but not limited to, managing outlook, or predictions for future periods are forward-looking statements. These statements are based solely on information that is now available to us. We encourage you to review the section entitled Cautionary Statements on Forward

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot